Clinical Trials Browser

Phase 3 × INDUSTRY × Chemotherapy-Induced Febrile Neutropenia × Clear all

NCT06711523 2025-11-25

Study Evaluating PEG-G-CSF Injectionin Preventing Neutropenia After Chemotherapy

Phase 3 Active not recruiting

Classical hematology

Chemotherapy-Induced Febrile Neutropenia

NCT02467868 2022-02-14

Efficacy and Safety Study With MYL-1401H and Neulasta

Phase 3 Completed

BreastClassical hematology

Breast Neoplasms, Neutropenia, Chemotherapy-Induced Febrile Neutropenia